Organon & Co.

NYSE:OGN

17.64 (USD) • At close October 17, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2023202220212020201920182017
Operating Activities:
Net Income 1,0239171,3512,1603,3062,1531,801
Depreciation & Amortization 2362121951573331,6731,973
Deferred Income Tax -485-18-28861237-1,045
Stock Based Compensation 101755940415656
Change In Working Capital -155-452702-197-672-174-1,435
Accounts Receivables -212-123-277159200250533
Inventory -230-220-138-29-914472
Accounts Payables 163-23766327-3520-14
Other Working Capital 124128454-354-746-488-2,026
Other Non Cash Items 791244397-253-585,480
Operating Cash Flow 7998582,4582,1872,7673,6873,419
Investing Activities:
Investments In Property Plant And Equipment -261-427-488-278-92-101-86
Acquisitions Net -2-124-185573230
Purchases Of Investments 0000000
Sales Maturities Of Investments 0000000
Other Investing Activites 313119215-173230
Investing Cash Flow -260-420-481-258-102-69-56
Financing Activities:
Debt Repayment -258-108-1,624-79-44-59-4
Common Stock Issued 01100000
Common Stock Repurchased -17-1100000
Dividends Paid -294-290-1450000
Other Financing Activities -17-35436-2,096-2,577-4,164-3,368
Financing Cash Flow -569-433-1,333-2,175-2,621-4,164-3,372
Other Information:
Effect Of Forex Changes On Cash 17-3623-33119-36
Net Change In Cash -13-31667-24975-527-45
Cash At End Of Period 69370673770319244771